Finance

Lists
017180:KRX
Myungmoon Pharm Co Ltd
â‚©1,208.00
+1.17%
(+14.00) 1D
Aug 28, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 017180...
Open
â‚©1,194
High
â‚©1,211
Low
â‚©1,176
Mkt. cap
41.02B
Avg. vol.
490.13K
Volume
53.80K
52-wk high
â‚©2,055
52-wk low
â‚©1,000
EPS
-â‚©49
Shares outstanding
33.95M
No. of employees
318
Open
â‚©1,194
High
â‚©1,211
Low
â‚©1,176
Mkt. cap
41.02B
Avg. vol.
490.13K
Volume
53.80K
52-wk high
â‚©2,055
52-wk low
â‚©1,000
EPS
-â‚©49
Shares outstanding
33.95M
No. of employees
318
About Myungmoon Pharm Co Ltd
CEO-
Employees318
Founded1983
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
49.86B
50.75B
48.00B
-
Cost of goods sold
23.26B
22.49B
21.26B
21.82B
Cost of revenue
23.26B
22.49B
21.26B
-
Research and development expenses
1.20B
1.24B
764.90M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.35B
25.30B
25.43B
29.00B
Operating expense
26.15B
26.65B
26.44B
-
Total operating expenses
49.41B
49.14B
47.71B
-
Operating income
453.76M
1.61B
293.53M
-
Other non operating income
374.15M
107.00M
1.08M
-
EBT including unusual items
-377.34M
477.71M
-931.61M
-
EBT excluding unusual items
-413.37M
451.92M
-933.44M
-
Income tax expense
290.58M
-350.59M
104.15M
-
Effective tax rate
-77.01%
-73.39%
-11.18%
-
Other operating expenses
513.85M
323.27M
334.38M
-
Net income
-548.97M
943.18M
-801.77M
-
Net profit margin
-1.10%
1.86%
-1.67%
-
Earnings per share
-
-
-
-
Interest and investment income
12.20M
149.26K
7.57M
-
Interest expense
-1.27B
-1.28B
-1.25B
-910.05M
Net interest expenses
-1.26B
-1.28B
-1.24B
-
Depreciation and amortization charges
175.00M
181.03M
176.03M
-
EBITDA
1.47B
2.60B
1.26B
-
Gain or loss from assets sale
6.73M
-22.85M
-3.00M
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps